Skip to content

A Study Comparing Two Medicines Used to Reverse Muscle Weakness After Anesthesia in Frail Patients

Comparison of neostigmine and sugammadex on residual neuromuscular bockade in frail patients: A randomized controlled trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108516
Enrollment
48
Registered
2026-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Sugammadex: Propofol 2 to 3 mg/kg, fentanyl 2 micrograms/kg and atracurium 0.5mg/kg or rocuronium 0.6mg/kg, sugammadex 2mg/kg body wt Intervention2: Nil: Nil Control Intervention1: Neos

Sponsors

Dr Puneet Khanna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age greater than 18 years of either sex 2. ASA physical status I-III 3. Open abdominal surgeries 4. Surgical duration greater than 1 hour 5. Patients with frailty score of greater or equal to 1 as defined by modified 5 item frailty index (5-mFI)

Exclusion criteria

Exclusion criteria: 1. H/o any neuromuscular disease 2. H/o psychiatric disease, dementia, anxiety disorder 3. Need for postoperative ICU admission 4. Patient with delirium on pre-operative assessment 5. Surgeries requiring rapid sequence intubation 6. Obese patients

Design outcomes

Primary

MeasureTime frame
1. Residual neuromuscular block 2. Recovery of Diaphragm Function 3. Postoperative Muscle Strength 4. Time to spontaneous recovery 5. Postoperative delirium 6. Postoperative adverse eventsTimepoint: 1. Within 5 minutes 2. Within 30 minutes 3. Within 30 minutes 4. Every 15 minutes 5. 24 hours post surgery 6. Continuous monitoring in PACU

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Puneet Khanna

All India Institute of Medical Sciences

k.punit@yahoo.com09873106516

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026